The effect of prescription drug monitoring programs on opioid utilization in medicare

American Economic Journal: Economic Policy

Volumn 10, Issue 1, 2018, Pages 77-112

  Buchmueller, Thomas C ^a   Carey, Colleen ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85041626154     PISSN: 19457731     EISSN: 1945774X     Source Type: Journal    
DOI: 10.1257/pol.20160094     Document Type: Article

References (48)

1. Agrawal, Shantanu. 2015. "Statement of Shantanu Agrawal, M.D., on Strengthening Program Integrity in Medicare Part D before the House Committee on Energy and Commerce." http://docs.house. gov/meetings/IF/IF02/20150714/103743/HHRG-114-IF02-Wstate-AgrawalS-20150714.pdf (accessed November 10, 2017).
2. Alpert, Abby, David Powell, and Rosalie Liccardo Pacula. 2016. "Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids." RAND Labor and Population Working Paper WR-1181.
3. Arditi, Lynn. 2014. "New law: Health-care providers must register in prescription database." Providence Journal, May 29. http://www.providencejournal.com/article/20140529/NEWS/305299995.
4. Bertrand, Marianne, Esther Duflo, and Sendhil Mullainathan. 2004. "How Much Should We Trust Differences-In-Differences Estimates?" Quarterly Journal of Economics 119 (1): 249-75.
5. Blum, Jonathan. 2014. "Testimony of Jonathan Blum." In Curbing Prescription Drug Abuse in Medicare, Hearing Before the Committee on Homeland Security and Governmental Affairs, 8-55. Washington, DC: US Government Printing Office.
6. Borgschulte, Mark, Adriana Corredor-Waldron, and Guillermo Marshall. 2017. "A Path Out: Prescription Drug Abuse and Suicide." https://docs.google.com/viewer?a=v&pid=sites&srcid=ZGVm YXVsdGRvbWFpbnxtYXJrYm9yZ3NjaHVsdGV8Z3g6NDIxYzYyYTU0ZmI4NzhjNw.
7. Brady, Joanne E., Hannah Wunsch, Charles J. DiMaggio, Barbara H. Lang, James Giglio, and Guohua Li. 2014. "Prescription drug monitoring and dispensing of prescription opioids." Public Health Reports 129 (2): 139-47.
8. Brewer, Mike, Thomas F. Crossley, and Robert Joyce. 2013. "Inference with Difference-in-Differences Revisited." Institute for the Study of Labor (IZA) Discussion Paper 7742.
9. Buchmueller, Thomas C., and Colleen Carey. 2018. "The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare: Dataset." American Economic Journal: Economic Policy.https://doi.org/10.1257/pol.20160094.
10. Cameron, A. Colin, Jonah B. Gelbach, and Douglas L. Miller. 2008. "Bootstrap-Based Improvements for Inference with Clustered Errors." Review of Economics and Statistics 90 (3): 414-27.
11. Case, Anne, and Angus Deaton. 2015. "Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century." Proceedings of the National Academy of Sciences 112 (49): 15078-83.
12. Center for Medicare and Medicaid Services (CMS). 2015. "Opioid Morphine Equivalent Conversion Factors." https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQ-Conversion-Factors-March-2015.pdf.
13. Chen, Li Hui, Holly Hedegaard, and Margaret Warner. 2014. "Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011." NCHS Data Brief 166: 1-8.
14. Dart, Richard C., Hilary L. Surratt, Theodore J. Cicero, Mark W. Parrino, S. Geoff Severtson, Becki Bucher-Bartelson, and Jody L. Green. 2015. "Trends in Opioid Analgesic Abuse and Mortality in the United States." New England Journal of Medicine 372 (3): 241-48.
15. Davis, Corey S., Matthew Pierce, and Nabarun Dasgupta. 2014. "Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011." American Journal of Public Health 104 (8): 1389-95.
16. Dowell, Deborah, Kun Zhang, Rita K. Noonan, and Jason M. Hockenberry. 2016. "Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates." Health Affairs 35 (10): 1876-83.
17. Edmonton Zone Palliative Care Program. 2016. "Instructions for Morphine Equivalent Daily Dose (MEDD)." http://palliative.org/NewPC/_pdfs/tools/INSTRUCTIONsMEDD.pdf.
18. Electronic-Florida Online Reporting of Controlled Substances Evaluation (E-FORCSE). 2012. 2011-2012 Prescription Drug Monitoring Program Annual Report. Florida Department of Health. Tallahassee, December.
19. Freeman, Patricia R., Amie Goodin, SuZanne Troske, and Jeffery Talbert. 2015. Kentucky House Bill 1 Impact Evaluation: Executive Summary. Institute for Pharmaceutical Outcomes and Policy. Lexington, KY, March.
20. Gourlay, Kristin. 2013. "Fighting Prescription Drug Abuse, One Log In At a Time." Rhode Island Public Radio, June 18. http://ripr.org/post/fighting-prescription-drug-abuse-one-log-time#stream/0.
21. Haegerich, Tamara M., Leonard J. Paulozzi, Brian J. Manns, and Christopher M. Jones. 2014. "What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose." Drug and Alcohol Dependence 145: 34-47.
22. Haffajee, Rebecca L., Anupam B. Jena, and Scott G. Weiner. 2015. "Mandatory Use of Prescription Drug Monitoring Programs." Journal of the American Medical Association 313 (9): 891-92.
23. Islam, M. Mofizul, and Ian S. McRae. 2014. "An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: Pros, cons and tensions." BMC Pharmacology and Toxicology 15 (46): 15-46.
24. Jena, Anupam B., Dana Goldman, Lesley Weaver, and Pinar Karaca-Mandic. 2014. "Opioid prescribing by multiple providers in Medicare: Retrospective observational study of insurance claims." British Medical Journal 348: g1393.
25. Kunins, Hillary V., Thomas A. Farley, and Deborah Dowell. 2013. "Guidelines for Opioid Prescription:Why Emergency Physicians Need Support." Annals of Internal Medicine 158 (11): 841-42.
26. Levy, Benjamin, Leonard Paulozzi, Karin A. Mack, and Christopher M. Jones. 2015. "Trends in Opioid Analgesic Prescribing Rates by Specialty, U.S., 2007-2012." American Journal of Preventive Medicine 49 (3): 409-13.
27. Li, Guohua, Joanne E. Brady, Barbara H. Lang, James Giglio, Hannah Wunsch, and Charles DiMaggio. 2014. "Prescription drug monitoring and drug overdose mortality." Injury Epidemiology 1 (9):1-8.
28. Manchikanti, Laxmaiah, Bert Fellows, Hary Ailinani, and Vidyasagar Pampati. 2010. "Therapeutic use, abuse, and nonmedical use of opioids: A ten-year perspective." Pain Physician 13 (5): 401-35.
29. Meara, Ellen, Jill R. Horwitz, Wilson Powell, Lynn McClelland, Weiping Zhou, A. James O'Malley, and Nancy E. Morden. 2016. "State Legal Restrictions and Prescription-Opioid Use among Disabled Adults." New England Journal of Medicine 375 (1): 44-53.
30. Morden, Nancy E., Jeffrey C. Munson, Carrie H. Colla, Jonathan Skinner, Julie P. W. Bynum, Weiping Zhou, and Ellen Meara. 2014. "Prescription opioid use among disabled Medicare beneficiaries:Intensity, trends, and regional variation." Medical Care 52 (9): 852-59.
31. Ohio Bureau of Workers' Compensation. 2016. "MED Table." https://www.bwc.ohio.gov/downloads/ blankpdf/MEDTable.pdf.
32. Pasero, Christine L., and Margo McCaffery. 1997. "Pain Ratings: The Fifth Vital Sign." American Journal of Nursing 97 (2): 15-16.
33. Patrick, Stephen W., Carrie E. Fry, Timothy F. Jones, and Melinda B. Buntin. 2016. "Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates." Health Affairs 35 (7): 1324-32.
34. Paulozzi, Leonard J., Edwin M. Kilbourne, and Hema A. Desai. 2011. "Prescription Drug Monitoring Programs and Death Rates from Drug Overdose." Pain Medicine 12 (5): 747-54.
35. Prescription Drug Monitoring Program Center of Excellence (PDMP). 2014. Mandating PDMP participation by medical providers: Current status and experience in selected states. Brandeis University. Waltham, MA, October.
36. Prescription Drug Monitoring Program Center of Excellence (PDMP). 2016. PDMP prescriber use mandates: Characteristics, current status, and outcomes in selected states. Brandeis University. Waltham, MA, May.
37. Reifler, Liza M., Danna Droz, J. Elise Bailey, Sidney H. Schnoll, Reginald Fant, Richard C. Dart, and Becki Bucher-Bartelson. 2012. "Do prescription monitoring programs impact state trends in opioid abuse/misuse?" Pain Medicine 13 (3): 434-42.
38. Sacarny, Adam, David Yokum, Amy Finkelstein, and Shantanu Agrawal. 2016. "Medicare Letters To Curb Overprescribing Of Controlled Substances Had No Detectable Effect On Providers." Health Affairs 35 (3): 471-79.
39. Solon, Gary, Steven J. Haider, and Jeffrey Wooldridge. 2015. "What Are We Weighting For?" Journal of Human Resources 50 (2): 301-16.
40. Substance Use and Mental Health Services Administration. 2014. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. US Department of Health and Human Services. Rockville, MD, September.
41. Unick, George Jay, Daniel Rosenblum, Sarah Mars, and Daniel Ciccarone. 2013. "Intertwined Epidemics:National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993-2009." PLOS One 8 (2): e54496.
42. United States General Accounting Office (GAO). 2002. Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion. United States General Accounting Office. Washington, DC, May.
43. United States General Accounting Office (GAO). 2011. Medicare Part D: Instances of Questionable Access to Prescription Drugs. United States General Accounting Office. Washington, DC, September.
44. Volkow, Nora D. 2014. "America's Addiction to Opioids: Heroin and Prescription Drug Abuse, Hearing Before the Caucus on International Narcotics Control." https://www.drugabuse.gov/ about-nida/legislative-activities/testimony-to-congress/2016/americas-addiction-to-opioidsheroin- prescription-drug-abuse (accessed November 10, 2017).
45. Washington State Agency Medical Directors' Group. 2010. Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain: An educational aid to improve care and safety with opioid therapy.Olympia, WA: Washington State Agency Medical Directors' Group.
46. West, Nancy A., Stevan G. Severtson, Jody L. Green, and Richard C. Dart. 2015. "Trends in abuse and misuse of prescription opioids among older adults." Drug and Alcohol Dependence 149: 117-21.
47. White House. 2015. Fact Sheet: Obama Administration Announces Public and Private Sector Efforts to Address Prescription Drug Abuse and Heroin Use. Washington, DC: Office of the Press Secretary.
48. Wisconsin Prescription Drug Monitoring Program. 2013. Training Guide for Wisconsin Practitioners and Pharmacists. Wisconsin Department of Safety and Professional Services. Madison, WI, October.